Skip to main content
Glow Lifetech logo

Glow Lifetech — Investor Relations & Filings

Ticker · GLOW ISIN · CA37989H1091 LEI · 5493000039SP09BBAI87 CSE Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2026-04-08 Regulatory Filings
Country CA Canada
Listing CSE GLOW

About Glow Lifetech

https://glowlifetech.com/

Glow Lifetech is a biotechnology company specializing in ingredient innovation for the nutraceutical and cannabinoid markets. The company supplies cutting-edge, natural active ingredients for functional foods, beverages, supplements, and personal care products. Its core technology is the proprietary MyCell® delivery system, which converts proprietary cannabinoids, vitamins, and botanicals into highly bioavailable, water-soluble liquid formats. This system is engineered to optimize absorption, ensuring dramatically improved bioavailability, faster onset (in as little as 20 minutes), enhanced stability, and a clean, neutral taste profile. Glow offers solutions ranging from foundational water-soluble ingredients and customized blends to fully market-ready products, serving as an innovation partner for companies seeking to launch and scale next-generation natural health products.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a corporate news release announcing completion of an airborne magnetic survey and exploration targets for a rare earth project. It contains no financial results, no regulatory form references, no management or governance changes, nor any investor presentation or earnings content. It is not announcing dividends, share issues, financing, M&A, or legal proceedings. It is a general project update/news release with forward-looking statements, fitting none of the specific categories, so we classify it under the fallback category Regulatory Filings (RNS).
2026-04-08 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release by Glow Lifetech announcing its fourth quarter and full year 2025 financial results, including key metrics, CEO commentary, and forward‐looking statements. It provides top‐line figures, non‐IFRS measures, and highlights rather than the full detailed financial statements or an attached annual report. These characteristics align with an Earnings Release (ER). FY 2025
2026-04-08 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Capital/Financing Update Classification · 1% confidence The document is a detailed prospectus/pricing supplement for a new issuance of structured notes (autocallable index‐linked notes) by The Bank of Nova Scotia. It outlines the financing terms, product structure, payment dates, and risk factors, which is characteristic of a capital raising/financing activity. Therefore, it best fits the "Capital/Financing Update" category (CAP).
2026-04-07 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Canadian securities regulatory form (Form 13-501F1) submitted to the Alberta Securities Commission, detailing participation fee calculations and including a management certification. It is not an earnings release, dividend notice, proxy statement, or financial report like an annual/quarterly report, nor is it a board change or M&A announcement. It is a miscellaneous regulatory filing form, so it falls under the fallback category “Regulatory Filings.”
2026-04-07 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a regulatory form (Form 13-502F1) submitted to the Ontario Securities Commission detailing the issuer’s quarterly market values and participation fee calculation under OSC Rule 13-502 Fees. It does not represent an annual or interim financial report, earnings release, share issue, management change, voting results, or any other specified category. Therefore it falls under the catch-all Regulatory Filings category.
2026-04-07 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a completed regulatory form (Form 13-501F1) submitted to the Alberta Securities Commission detailing market value calculations and the participation fee due. It is not an annual or interim financial report, earnings release, corporate announcement of board changes, or other specific corporate filing category. It is a compliance/regulatory submission, fitting the fallback “Regulatory Filings” category.
2026-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.